A clinical study of docetaxel with or without 5′DFUR as a second-line chemotherapy for advanced gastric cancer

Author: Maruta Fukuto   Ishizone Satoshi   Hiraguri Manabu   Fujimori Yoshiro   Shimizu Fumiaki   Kumeda Shigeyoshi   Miyagawa Shinichi  

Publisher: Humana Press, Inc

ISSN: 1357-0560

Source: Medical Oncology, Vol.24, Iss.1, 2007-01, pp. : 71-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content